Leading the Way in Life Science Technologies

GEN Exclusives

More »

April 15, Vol. 30, No. 8

  • Feature Articles

    • Healthcare Reform on the Way
    • Gail Dutton
    • A detailed pathway for FDA approval of biosimilars was signed into law on March 23 as part of HR 3590, The Patient Protection and Affordable Care Act That single provision ended years of debate and is considered a major achievement ... more »
    • Interview with BIO's James Greenwood
    • James Greenwood is president and CEO of the Biotechnology Industry Organization in Washington, DC BIO represents more than 1,200 biotechnology companies, academic institutions, state biotech centers, and related organizations across the US and in more than 30 other nations... more »
    • New Tools for Dealing with Data Overload
    • Catherine Shaffer
    • As high-throughput screening technologies are producing increasingly vast quantities of data, correspondingly robust data-analysis tools are necessary to help scientists sift through it for usable information One solution to the problem is to use bigger, more powerful computers However, software ... more »
    • Third-Generation Sequencing Debuts
    • Vicki Glaser
    • Third-generation (gen-3), single-molecule sequencing technology is not only about making quantifiable enhancements to second-generation (gen-2) capabilities, but also about improving data quality and expanding the types of data produced “It is becoming clear that we will need information about the ... more »
    • Viral Safety Methods for Manufacturing
    • Angelo DePalma
    • The growing significance of biotherapeutics, particularly monoclonal antibodies (mAbs), assures that increased demand for virus-safety products and services will continue, despite the trend toward a more risk-based approach to virus removal and inactivation... more »